BETA
Start SIP
Invest Now
Start SIP in BETA
Performance
- Low
- ₹1,501
- High
- ₹1,570
- 52 Week Low
- ₹1,430
- 52 Week High
- ₹2,030
- Open Price₹1,530
- Previous Close₹1,554
- Volume7,230
Investment Returns
- Over 1 Month -9.43%
- Over 3 Month -16.51%
- Over 6 Month -14.82%
- Over 1 Year -23.35%
Smart Investing Starts Here Start SIP with Beta Drugs for Steady Growth!
Beta Drugs Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- -
- PEG Ratio
- -
- Market Cap Cr
- 1,527
- P/B Ratio
- 6.9
- Average True Range
- 69.96
- EPS
- 45.36
- Dividend Yield
- 0
- MACD Signal
- -32.92
- RSI
- 35.04
- MFI
- 12.11
Beta Drugs Financials
Beta Drugs Technicals
EMA & SMA
Current Price
₹1,512.80
-41.4
(-2.66%)
- Bearish Moving Average 16
- Bullish Moving Average 0
- 20 Day
- ₹1,603.86
- 50 Day
- ₹1,664.83
- 100 Day
- ₹1,714.51
- 200 Day
- ₹1,730.19
Resistance and Support
1527.8
- R3 1,622.90
- R2 1,596.20
- R1 1,554.50
- S1 1,486.10
- S2 1,459.40
- S3 1,417.70
Beta Drugs Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-06 | Quarterly Results | |
| 2025-05-15 | Audited Results | |
| 2025-03-27 | Others | To consider other business matters :- The allotment of 4,80,693 fully paid-up equity shares of the Company of face value of INR 10 each, under Bonus Issue. issue of equity shares in the ratio of 1:20 of Rs. 10/-. |
| 2025-02-05 | Issue of Bonus & Others | To consider other business matters. issue of equity shares in the ratio of 1:20 of Rs. 10/-. |
| 2024-11-06 | Quarterly Results |
Beta Drugs F&O
About Beta Drugs
- NSE Symbol
- BETA
- BSE Symbol
- 531481
- Chairperson & Managing Director
- Mr. Rahul Batra
- ISIN
- INE351Y01019
Similar Stocks to Beta Drugs
Beta Drugs FAQs
Beta Drugs share price is ₹1,512 As on 30 December, 2025 | 00:38
The Market Cap of Beta Drugs is ₹1527.1 Cr As on 30 December, 2025 | 00:38
The P/E ratio of Beta Drugs is As on 30 December, 2025 | 00:38
The PB ratio of Beta Drugs is 6.9 As on 30 December, 2025 | 00:38
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.